Enterotoxigenic Clostridium perfringens infection and pediatric patients with inflammatory bowel disease
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enterotoxigenic Clostridium perfringens infection and pediatric patients with inflammatory bowel disease
Authors
Keywords
-
Journal
Journal of Crohns & Colitis
Volume 8, Issue 4, Pages 276-281
Publisher
Oxford University Press (OUP)
Online
2013-09-22
DOI
10.1016/j.crohns.2013.08.018
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A New Strategy for the Prevention of Clostridium difficile Infection
- (2013) Amber Howerton et al. JOURNAL OF INFECTIOUS DISEASES
- Microbiota of De-Novo Pediatric IBD: Increased Faecalibacterium Prausnitzii and Reduced Bacterial Diversity in Crohn's But Not in Ulcerative Colitis
- (2012) Richard Hansen et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Non-Invasive Mapping of the Gastrointestinal Microbiota Identifies Children with Inflammatory Bowel Disease
- (2012) Eliseo Papa et al. PLoS One
- The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?
- (2012) Justyna Bien et al. Therapeutic Advances in Gastroenterology
- Gastrointestinal infection as a trigger for inflammatory bowel disease
- (2011) Elizabeth A. Mann et al. CURRENT OPINION IN GASTROENTEROLOGY
- Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives
- (2011) M. Joossens et al. GUT
- Alterations in diversity of the oral microbiome in pediatric inflammatory bowel disease
- (2011) Michael J. Docktor et al. INFLAMMATORY BOWEL DISEASES
- Clostridium difficile Infection and Treatment in the Pediatric Inflammatory Bowel Disease Population
- (2011) Ethan Mezoff et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Systematic review: Clostridium difficile and inflammatory bowel disease
- (2010) J. R. Goodhand et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease
- (2010) D. Wultańska et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Through Ageing, and Beyond: Gut Microbiota and Inflammatory Status in Seniors and Centenarians
- (2010) Elena Biagi et al. PLoS One
- Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections
- (2009) S. SCHNEEWEISS et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
- (2009) J.F. Rahier et al. Journal of Crohns & Colitis
- Impact of Clostridium difficile Infection on Pediatric Inflammatory Bowel Disease
- (2009) Filomena Pascarella et al. JOURNAL OF PEDIATRICS
- Clostridium difficileinfection and inflammatory bowel disease
- (2009) Saif Musa et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Clostridium perfringens toxin genotypes in the feces of healthy North Americans
- (2008) Robert J. Carman et al. ANAEROBE
- Spread of a large plasmid carrying the cpe gene and the tcp locus amongst Clostridium perfringens isolates from nosocomial outbreaks and sporadic cases of gastroenteritis in a geriatric hospital
- (2008) S. KOBAYASHI et al. EPIDEMIOLOGY AND INFECTION
- Noncytotoxic Clostridium perfringens Enterotoxin (CPE) Variants Localize CPE Intestinal Binding and Demonstrate a Relationship between CPE-Induced Cytotoxicity and Enterotoxicity
- (2008) J. G. Smedley et al. INFECTION AND IMMUNITY
- Clostridium difficile and inflammatory bowel disease
- (2008) Mazen Issa et al. INFLAMMATORY BOWEL DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started